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There is a significant cost associated with process development of a portfolio of 
pharmaceutical products, few of which will reach the market. Continuous 
processing will increase the “chemical space” which can increase development 
efficiency. For example one, particularly attractive option is to develop 
manufacturing processes based on modular continuous systems; a flexible 
generic continuous modular plant which can be adapted for different substrates. 
In the work reported here, a substrates adoption methodology (SAM) has been 
developed. The proposed SAM identifies the necessary changes to a template 
recipe & flowsheet in order to adapt it for a given substrate. The changes can 
be related to reagents (e.g. reducing agent, solvent, catalyst), process 
conditions (e.g. operating temperature, flow rates), as well as in the physical 
arrangement (configuration) of the modular process equipment within the 
template. In this way the substrates adoption methodology helps to achieve 
“fast, flexible, future (F3)” pharmaceutical production processes by adapting a 
recently designed generic modular process-plant. The supporting tools for the 
substrate adoption are: (1) an ontological knowledge-base consisting of the 
properties of substances, reaction characteristics and characteristics of unit 
operations; and (2) a model library consisting of the mathematical models. 
The objective of this presentation is two-fold: First to highlight the substrates 
adoption framework and the associated models, methods and tools, and second 
to demonstrate its applications using a pharmaceutical manufacturing case 
study involving the nitro reduction of 2-Nitro-4’-chlorodiphenylamine. 
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